Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Fluoxetine Prevention Trial

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified February 2016 by University of California, Los Angeles
Sponsor:
Collaborator:
Beckman Research Institute
Information provided by (Responsible Party):
Daniel H. Silverman, University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT01615055
First received: June 6, 2012
Last updated: February 4, 2016
Last verified: February 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: October 2020
  Estimated Primary Completion Date: October 2020 (Final data collection date for primary outcome measure)